Exenatide for weight‐loss maintenance in adolescents with severe obesity: A randomized, placebo‐controlled trial

Abstract

Although not achieving statistical significance, exenatide XR, compared with placebo, may partly mitigate the propensity toward BMI rebound in adolescents who achieved initial weight loss with dietary intervention.